Global and China Industrial Enzyme Industry Report, 2014-2017
  • June 2015
  • Hard Copy
  • USD $2,150
  • Pages:85
  • Single User License
    (PDF Unprintable)       
  • USD $2,000
  • Code: ZLC020
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,100
  • Hard Copy + Single User License
  • USD $2,350
      

In recent years, the global industrial enzyme preparation market size increased year by year, registering a CAGR of 5%, approximating USD4.2178 billion in 2014. At present, the global industrial enzyme market is basically an oligopoly. In 2014, Novozymes, an industrial enzyme giant, accounted for a 44% market share while that for Dupont and DSM was 20% and 6%, respectively.

Regionally, Europe and North America have the largest demand for industrial enzyme, occupying nearly 80% in sharp contrast to some 9.4% in China.

Stimulated by the growing demand for enzyme preparations and favorable policies, China's industrial enzyme preparation output reached 1.1657 million tons in 2014. For years to come, industrial enzyme output will keep 10% growth rate, to 1.5487 million tons by 2017.

By introducing foreign advanced equipment, excellent strains, and new-type enzyme preparations, China has scored rapid development of enzyme preparation industry, especially the Chinese enzyme preparation enterprises. Currently, the enterprises with strong competitive power in China include VTR Bio-Tech, Youtell Biochemical, Smistyle, SunHY, etc.

As an enzyme preparation leader in China, VTR Bio-Tech has two subsidiaries: VTR Bio-Tech (Inner Mongolia) and Hunan Hong Ying Xiang Biochemistry (acquiring a 75% stake in 2014), with an annual capacity of 186,000 tons. In 2014, the company recorded revenue of RMB359.82 million and net income of RMB55.13 million (excluding that of Hunan Hong Ying Xiang). At present, VTR Bio-Tech (Inner Mongolia)’s 20,000 tons/a enzyme preparation project and Hunan Hong Ying Xiang’s 140,000 tons/a enzyme preparation project have been jumpstarted.

Youtell boasts advanced R&D center in the United States and two large fermentation production bases in Hunan and Shandong, with the annual production scale approaching 80,000 tons but lower capacity utilization. In 2014, the company posted RMB153.9 million in revenue and RMB10.74 million in net income.

Global and China Enzyme Preparation Industry, 2014-2017 is all about the following:
20120114.gifDevelopment of global industrial enzyme industry, including market size, competition pattern, and demand structure;
20120114.gifDevelopment of China’s industrial enzyme industry, including development history, policy environment, development status, import and export, and competition pattern;
20120114.gifDevelopment of downstream sectors of China’s enzyme preparation industry, including food, feedstuff, brewing, detergent, papermaking, and textile industries;
20120114.gifFour global and nine major Chinese industrial enzyme manufacturers, including their profile, operation, and their industrial enzyme business.

酶制剂 英文_副本改.png

1 Overview of Industrial Enzyme 

2 Development of Global Industrial Enzyme Industry 
2.1 Market Size 
2.2 Competition Pattern
2.3 Demand Structure

3 Development of China Industrial Enzyme Industry
3.1 Development History
3.2 Policy Environment
3.3 Development Status
3.4 Import and Export
3.4.1 Import
3.4.2 Export
3.5 Competition Pattern 

4 Development of Downstream Sectors of China Enzyme Preparation Industry
4.1 Food Industry
4.1.1 Starch Processing
4.1.2 Bakery Product
4.1.3 Condiments
4.2 Feedstuff Industry
4.3 Brewing Industry
4.3.1 Spirit
4.3.2 Beer
4.3.3 Wine
4.3.4 Yellow Wine
4.4 Detergent Industry
4.5 Papermaking Industry
4.6 Textile Industry

5 Major Foreign Companies
5.1 Novozymes 
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 R&D and Investment
5.1.6 Development in China
5.2 ABF
5.2.1 Profile
5.2.2 Operation
5.2.3 Revenue Structure
5.2.4 Gross Margin
5.2.5 R&D
5.2.6 Enzyme Business
5.2.7 Development in China
5.3 DSM
5.3.1 Profile
5.3.2 Operation
5.3.3 Revenue Structure
5.3.4 Gross Margin
5.3.5 R&D and Investment
5.3.6 Enzyme Business
5.3.7 Development in China
5.4 Danisco (Genencor)
5.4.1 Profile
5.4.2 Development in China

6 Major Domestic Companies
6.1 VTR Bio-Tech
6.1.1 Profile
6.1.2 Operation
6.1.3 Revenue Structure
6.1.4 Gross Margin
6.1.5 R&D and Investment
6.1.6 Production and Sales
6.1.7 Major Clients
6.1.8 Forecast and Outlook
6.2 Youtell Biochemical
6.2.1 Profile
6.2.2 Operation
6.2.3 Development History
6.3 Beijing Challenge Bio-technology
6.3.1 Profile
6.3.2 Operation
6.4 Smistyle
6.4.1 Profile
6.4.2 Operation
6.5 Longda Bio-products 
6.5.1 Profile
6.5.2 Operation
6.6 Vland Biotech
6.6.1 Profile
6.6.2 Operation
6.7 SunHY
6.7.1 Profile
6.7.2 Operation
6.7.3 R&D
6.8 Sunson 
6.8.1 Profile
6.8.2 Operation
6.9 Senzymes Biotechnology
6.9.1 Profile
6.9.2 Operation

7 Forecast and Outlook 
7.1 Global Industrial Enzyme Market
7.2 China Industrial Enzyme Market
Classification of Enzyme (by Nature of Catalytic Reaction) 
Biological Enzyme Preparation Production Technology and Core Technology
Global Industrial Enzyme Preparation Market Size and YoY Growth Rate, 2007-2014
Global Industrial Enzyme Market Share, 2014 
Global Industrial Enzyme Demand Structure (by Region), 2014
Development History of China’s Industrial Enzyme Preparation Industry
Policies on China’s Industrial Enzyme Preparation Industry
China’s Industrial Enzyme Preparation Output and YoY Growth, 2006-2014
China’s Industrial Enzyme Preparation Output (by Product), 2014
China’s Industrial Enzyme Preparation Output Percentage (by Product), 2014
China’s Industrial Enzyme Preparation Import Volume and YoY Growth Rate, 2009-2014
China’s Industrial Enzyme Preparation Import Value and YoY Growth Rate, 2009-2014  
Top 10 Countries and Regions by Import Volume of China’s Industrial Enzyme Preparations, 2014 
China's Industrial Enzyme Preparation Export Volume and YoY Growth Rate, 2009-2014
China's Industrial Enzyme Preparation Export Value and YoY Growth Rate, 2009-2014
Top 10 Countries and Regions by Export Volume of China’s Industrial Enzyme Preparations, 2014
Average Price of China's Industrial Enzyme Preparation Import and Export, 2009-2014
Capacity of Major Enzyme Preparation Manufacturers in China, 2014  
China's Starch Output, 2009-2014 
China’s Starch Output Percentage by Product, 2014
China’s Starch Import and Export by Product, 2013-2014 
Revenue and Total Profit of Chinese Bakery Enterprises, 2008-2014
Revenue and Total Profit of Chinese Condiment Enterprises, 2008-2014  
China's Feedstuff Output and YoY Growth Rate, 2009-2014 
China’s Mixed Feed Output and YoY Growth Rate, 2009-2014 
China’s Premix Feedstuff Output and YoY Growth Rate, 2009-2014 
China's Additive Premix Feedstuff Output and YoY Growth Rate, 2009-2014
China’s Feedstuff additive Output Percentage by Category, 2014  
China's Spirit Output and YoY Growth Rate, 2009-2014
Revenue and Total Profit of Chinese Spirit Companies, 2009-2014 
Application of Various Enzyme Products in Beer Brewing
China's Beer Output and YoY Growth Rate, 2009-2014  
Revenue and Total Profit of Chinese Beer Enterprises, 2009-2014 
China's Wine Output and YoY Growth, 2009-2014
Revenue and Total Profit of Chinese Wine Enterprises, 2009-2014
Revenue and Total Profit of Chinese Yellow Wine Enterprises, 2009-2014
China's Synthetic Detergent Output and YoY Growth, 2009-2014 
China's Detergent Export Volume and YoY Growth, 2009-2014
China's Pulp Output and YoY Growth, 2009-2014  
China's Pulp Import Volume and YoY Growth, 2009-2014  
China's Fabric Output and YoY Growth, 2009-2014  
Novozymes’ Revenue and Net Income, 2010-2014  
Novozymes’ Revenue Breakdown by Sector, 2012-2014  
Novozymes’ Revenue Structure by Sector, 2012-2014  
Novozymes’ Revenue Breakdown by Region, 2013-2014  
Novozymes’ Revenue Structure by Region, 2013-2014  
Novozymes’ Gross Margin, 2010-2014  
Novozymes’ R&D Costs and % of Total Revenue, 2012-2014   
Novozymes’ M&A Progress and Engineering Construction, 1967-2013  
Novozymes’ Milestones in China and Big Events
Registered Capital and Shareholding Ratio of Novozymes’ Subsidiaries in China 
ABF’s Revenue and Net Income, FY2012-FY2014  
ABF’s Revenue Breakdown by Segment, FY2012-FY2014  
ABF’s Revenue Structure by Segment, 2012-2014  
ABF’s Gross Margin, 2012-2014  
ABF’s R&D Costs and % of Total Revenue, 2012-2014  
ABF’s Ingredient Revenue and % of Total Revenue, FY2012-FY2014  
DSM’s Revenue and Net Income, 2010-2014  
DSM’s Revenue Breakdown by Segment, 2013-2014  
DSM’s Revenue Structure by Segment, 2013-2014  
DSM’s Revenue Breakdown by Region, 2010-2014  
DSM’s Revenue Structure by Region, 2010-2014  
DSM’s Gross Margin’s 2010-2014  
DSM’s R&D Costs and % of Total Revenue, 2010-2014  
DSM’s Nutrition Revenue, YoY Growth, and % of Total Revenue, 2010-2014
DSM’s Development in China
DSM’s Major Arms in China
DSM’s Revenue, YoY Growth, and % of Total Revenue in China, 2010-2014  
Danisco’s Operating Companies in China 
VTR Bio-Tech’s Revenue and Net Income, 2010-2014  
VTR Bio-Tech’s Revenue Breakdown by Product, 2010-2014  
VTR Bio-Tech’s Revenue Structure by Product, 2010-2014  
VTR Bio-Tech’s Revenue Breakdown by Region, 2010-2014   
VTR Bio-Tech’s Revenue Structure by Region, 2010-2014  
VTR Bio-Tech’s Gross Margin of VTR Bio-Tech, 2010-2014  
VTR Bio-Tech’s Gross Margin by Product, 2010-2014  
VTR Bio-Tech’s Gross Margin by Region, 2010-2014  
VTR Bio-Tech’s R&D Costs and % of Total Revenue, 2010-2014  
Major Research Projects of VTR Bio-Tech as of the End of 2014
VTR Bio-Tech’s Production and Sales by Product, 2013-2014  
VTR Bio-Tech’s Revenue from Top 5 Clients and % of Total Revenue, 2010-2014  
VTR Bio-Tech’s Revenue and Net Income, 2013-2017E
Youtell's Revenue and Net Income, 2010-2014 
Youtell's Total Assets, Net Assets, and Asset-liability Ratio, 2010-2014  
Youtell's Development History
SunHY's Subsidiaries
SunHY's Main Product Lines 
Global Industrial Enzyme Preparation Market Size and YoY Growth, 2013-2017E
China's Industrial Enzyme Preparation Output and YoY Growth, 2013-2017E

China Contract Research Organization (CRO) Industry Report, 2015-2018

In recent years, China's contract research organization (CRO) industry has developed rapidly, with the market size rising from RMB8.5 billion in 2007 to RMB42.6 billion in 2014, registering a CAGR of ...

Global and China Industrial Enzyme Industry Report, 2014-2017

In recent years, the global industrial enzyme preparation market size increased year by year, registering a CAGR of 5%, approximating USD4.2178 billion in 2014. At present, the global industrial enzym...

China Blood Product Industry Report, 2015-2018

Recombinant blood products have developed for many years in foreign countries, but China’s blood products are still proteins extracted from human blood. Thus, reserves and control of plasma resources ...

China Human Vaccine Industry Report, 2015-2018

A vaccine is a preventive biological product for human use that prevents and controls the occurrence and prevalence of infectious diseases, so the demand for such products is relatively rigid. Due to ...

China Vacuum Blood Collection Industry Report, 2014-2017

The vacuum blood collection system consisting of vacuum blood collection tubes, disposable blood collection needles, tourniquets, etc transfers human venous blood to closed containers and makes it int...

China Pharmaceutical Excipients Industry Report, 2014-2017

Pharmaceutical excipients refer to adjuvants and additives used for production of pharmaceuticals and compounding of prescriptions. In addition to active ingredients, pharmaceutical excipients are als...

China Recombinant Protein Drug Industry Report, 2014-2017

The Chinese recombinant protein drug market has been expanding rapidly owing to the improvement of demand rigidity, consumption ability and the like. During 2005-2013, sales of recombinant protein dru...

China Heparin Industry Report, 2014-2017

As the world's major heparin API producer and exporter, China boasts enormous raw materials, which provides a strong support for the production of China’s heparin products. In 2013, the live pigs rais...

Global and China Monoclonal Antibody Industry Report, 2014-2019

Despite world-wide economic downturn and great changes in exchange rate, benefiting from robust market demand, global monoclonal antibody market size exceeded USD 80 billion in 2013, still one of biot...

Global and China DNA Sequencing Industry Research Report, 2014-2017

DNA sequencing is the process of reading nucleotide bases in a specific DNA molecule, that is to say determining the arrangement mode of adenine, thymine, cytosine, and guanine. It can be applied in a...

Global and China Stem Cell Industry Report, 2014-2017

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Stem cell therapy can be applied to treatmen...

China Human Vaccine Industry Report, 2014-2017

Vaccines can prevent and control infectious diseases, so the demand for these biological products is relatively rigid. In 2013, China’s human vaccine lot release volume grew by 4.9% from a year earlie...

China Blood Product Industry Report, 2014-2017

Plasma resource reserves and control are crucial to the development of blood products industry. Although the closure of 16 plasma collection stations in Guizhou in 2011 didn’t cause major disruption t...

China Animal Vaccine Industry Report, 2013-2016

Animal vaccine is a kind of biological agent that enables inoculated animals to produce active immunity for disease prevention. Europe and the United States and other developed countries are the main ...

China Contract Research Organization (CRO) Industry Report, 2013-2016

China CRO industry has developed rapidly in recent years, registering a CAGR of 27.2% during 2007-2013, of which the market size reached RMB 36 billion in 2013, occupying 10% of global market share. ...

Global and China Biodegradable Plastics Industry Report, 2013-2016

Global biodegradable plastic production and demand have grown rapidly in recent years, and the capacity reached 1-1.5 million t/a in 2012-2013. Among dozens of biodegradable plastic varieties develope...

Global and China Industrial Enzyme Industry Report, 2014-2016

In 2007-2013, the global industrial enzyme market size grew at the CAGR of 5.7%, reaching USD4.04 billion in 2013, 1.4 times that in 2007. The global industrial enzyme market is monopolized by a small...

China Heparin Industry Report, 2013-2015

Since the small intestines of pigs (raw materials for production of heparin) in China are abundant (the pig slaughtering volume in China approximates 50% of globe’s total) and heparin APIs are gradual...

2005-2014 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号
在线客服系统